Cargando...
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer
PURPOSE: We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal hormone therapy (CHT): progesterone, dydrogesterone, or other progestagens. We conducted the present study to assess how these CHTs were associated with histo...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Clinical Oncology
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2346534/ https://ncbi.nlm.nih.gov/pubmed/18323549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.4338 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|